Latest News & Updates
We are hard at work developing personalized T cell therapies for people living with cancer. Explore our latest news and updates.
PACT Pharma Announces Planned Retirement of CEO Alex Franzusoff, Veteran Biotech Executive Scott Garland Named as Successor
PACT Pharma, Inc. today announced the appointment of Scott Garland as Chief Executive Officer. Mr. Garland assumes the CEO role effective today, succeeding Alex Franzusoff, Ph.D., who will be staying with the company through mid-year in an advisory role to support the transition.
PACT Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference
PACT Pharma, Inc., a clinical-stage company developing transformational personalized neoTCR-T cell therapies for the eradication of solid tumors, today announced that the company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on January 11, 2021 at 7:30 a.m. PT/10:30 a.m. ET.
Cellares Adds PACT Pharma to its Early Access Partnership Program
Cellares Corporation, a company focused on revolutionizing cell therapy manufacturing, announced that PACT Pharma, Inc., a clinical-stage company developing transformational personalized NeoTCR-T cell therapies for the eradication of solid tumors, has joined its Early Access Partnership Program (EAPP).
A High-throughput Platform To Produce NeoE-HLA Libraries For Capturing NeoE-specific T Cells From Peripheral Blood Of Patients With Solid Tumors
Presentation at AACR Annual Meeting 2020
Non-viral genome engineering method allows highly efficient, single-step removal and precise insertion
Presentation at AACR Annual Meeting 2020